Polymorphisms in the Steroid and Xenobiotic Receptor Gene Influence Survival in Primary Sclerosing Cholangitis

Chapman, 1980, Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology, Gut, 21, 870, 10.1136/gut.21.10.870 Brandsaeter, 2003, Outcome following liver transplantation for primary sclerosing cholangitis in the Nordic countries, Scand J Gastroenterol, 38, 1176, 10.1080/00365520310006009 Loftus, 2005, PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis, Gut, 54, 91, 10.1136/gut.2004.046615 Bergquist, 2005, Increased prevalence of primary sclerosing cholangitis among first-degree relatives, J Hepatol, 42, 252, 10.1016/j.jhep.2004.10.011 Donaldson, 2001, Immunogenetics in PSC, Best Pract Res Clin Gastroenterol, 15, 611, 10.1053/bega.2001.0208 Spurkland, 1999, HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations, Tissue Antigens, 53, 459, 10.1034/j.1399-0039.1999.530502.x Talwalkar, 2001, Natural history and prognostic models in primary sclerosing cholangitis, Best Pract Res Clin Gastroenterol, 15, 563, 10.1053/bega.2001.0205 Cullen, 2005, Review article: current management of primary sclerosing cholangitis, Aliment Pharmacol Ther, 21, 933, 10.1111/j.1365-2036.2005.02407.x Trauner, 2003, Bile salt transporters: molecular characterization, function, and regulation, Physiol Rev, 83, 633, 10.1152/physrev.00027.2002 Orans, 2005, The nuclear xenobiotic receptor PXR: recent insights and new challenges, Mol Endocrinol, 19, 2891, 10.1210/me.2005-0156 Schuetz, 2001, Promiscuous regulator of xenobiotic removal, Nat Med, 7, 536, 10.1038/87856 Parks, 1999, Bile acids: natural ligands for an orphan nuclear receptor, Science, 284, 1365, 10.1126/science.284.5418.1365 Boyer, 2005, Nuclear receptor ligands: rational and effective therapy for chronic cholestatic liver disease?, Gastroenterology, 129, 735, 10.1016/j.gastro.2005.06.053 Staudinger, 2001, The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity, Proc Natl Acad Sci U S A, 98, 3369, 10.1073/pnas.051551698 Xie, 2001, An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids, Proc Natl Acad Sci U S A, 98, 3375, 10.1073/pnas.051014398 Stedman, 2005, Nuclear receptors constitutive androstane receptor and pregnane X receptor ameliorate cholestatic liver injury, Proc Natl Acad Sci U S A, 102, 2063, 10.1073/pnas.0409794102 Wagner, 2005, CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice, Hepatology, 42, 420, 10.1002/hep.20784 Schuetz, 2001, Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome P450, J Biol Chem, 276, 39411, 10.1074/jbc.M106340200 Zhang, 2001, The human pregnane X receptor: genomic structure and identification and functional characterization of natural allelic variants, Pharmacogenetics, 11, 555, 10.1097/00008571-200110000-00003 Uno, 2003, Characterization of six base pair deletion in the putative HNF1-binding site of human PXR promoter, J Hum Genet, 48, 594, 10.1007/s10038-003-0076-5 Langmann, 2004, Loss of detoxification in inflammatory bowel disease: dysregulation of pregnane X receptor target genes, Gastroenterology, 127, 26, 10.1053/j.gastro.2004.04.019 Oswald, 2001, Expression of hepatic transporters OATP-C and MRP2 in primary sclerosing cholangitis, Liver, 21, 247, 10.1034/j.1600-0676.2001.021004247.x Dring, 2006, The pregnane X receptor locus is associated with susceptibility to inflammatory bowel disease, Gastroenterology, 130, 341, 10.1053/j.gastro.2005.12.008 Kimura, 2005, Genetic polymorphisms influencing xenobiotic metabolism and transport in patients with primary biliary cirrhosis, Hepatology, 41, 55, 10.1002/hep.20516 Fausa, 1991, Relationship of inflammatory bowel disease and primary sclerosing cholangitis, Semin Liver Dis, 11, 31, 10.1055/s-2008-1040420 Bergquist, 2002, Hepatic and extrahepatic malignancies in primary sclerosing cholangitis, J Hepatol, 36, 321, 10.1016/S0168-8278(01)00288-4 Barker, 2004, Two methods of whole-genome amplification enable accurate genotyping across a 2320-SNP linkage panel, Genome Res, 14, 901, 10.1101/gr.1949704 Colhoun, 2003, Problems of reporting genetic associations with complex outcomes, Lancet, 361, 865, 10.1016/S0140-6736(03)12715-8 Gabriel, 2002, The structure of haplotype blocks in the human genome, Science, 296, 2225, 10.1126/science.1069424 van der Linden, 2001, Six microsatellite markers on the short arm of chromosome 6 in relation to HLA-DR3 and TNF-308A in systemic lupus erythematosus, Genes Immun, 2, 373, 10.1038/sj.gene.6363794 Handschin, 2003, Induction of drug metabolism: the role of nuclear receptors, Pharmacol Rev, 55, 649, 10.1124/pr.55.4.2 Drumm, 2005, Genetic modifiers of lung disease in cystic fibrosis, N Engl J Med, 353, 1443, 10.1056/NEJMoa051469 Marschall, 2005, Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans, Gastroenterology, 129, 476, 10.1016/j.gastro.2005.05.009 Chen, 2006, Nuclear receptors, bile-acid detoxification, and cholestasis, Lancet, 367, 454, 10.1016/S0140-6736(06)68156-7 Komichi, 2005, Glycochenodeoxycholate plays a carcinogenic role in immortalized mouse cholangiocytes via oxidative DNA damage, Free Radic Biol Med, 39, 1418, 10.1016/j.freeradbiomed.2005.07.005 Cardon, 2003, Using haplotype blocks to map human complex trait loci, Trends Genet, 19, 135, 10.1016/S0168-9525(03)00022-2